Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
237
-
Total shares
-
4.18M
-
Shares change
-
-426K
-
Total reported value, excl. options
-
$612M
-
Value change
-
-$62.8M
-
Put/Call ratio
-
0.02
-
Number of buys
-
71
-
Number of sells
-
-119
-
Price
-
$146.35
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2023
239 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q3 2023.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.18M shares
.
Largest 10 shareholders include MORGAN STANLEY (647K shares), WELLS FARGO & COMPANY/MN (447K shares), BANK OF AMERICA CORP /DE/ (322K shares), UBS Group AG (268K shares), Royal Bank of Canada (222K shares), LPL Financial LLC (184K shares), Raymond James Financial Services Advisors, Inc. (172K shares), RAYMOND JAMES & ASSOCIATES (126K shares), Berger Financial Group, Inc (114K shares), and OSAIC HOLDINGS, INC. (99.7K shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.